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•  A 24-year-old  male presented with 4-month history of facial flushing, weight gain, abdominal pain, 
increasing abdominal girth and significant hypertension.
•  Physical exam showed cushingoid facies with facial plethora, abdominal distention and associated 
tenderness. 
•  Patient noted a history of hospitalization 7-months ago for a motor vehicle accident. CT scan ruled out 
internal trauma but revealed a right adrenal incidentaloma measuring 3cm x 2.6cm x 3cm (Figure A). 
The patient was discharged and unfortunately lost to follow up.
•  A CT scan done during current admission showed the right adrenal mass increased in size to 8.9cm 
x9.1cmx 6cm (Figure B). 
•  A comprehensive endocrine work up showed the mass to be functional with overall findings consistant 
with cushing syndrome (Table 1). 
•  He further underwent right adrenalectomy with pathology confirming high grade adrenocortical 
carcinoma with clinical stage II, T2 N0 M0.
•  Despite surgery and aggressive adjuvant chemotherapy, cancer 
progressed rapidly in 6 months to reach a massive size (Figure 
C and D). 
•  The patient survived only 7 months after initial chemotherapy. 
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CASE PRESENTATION
•  Adrenal incidentalomas are masses 1cm or greater, identified incidentally on imaging performed for 
indications other than for an evaluation of adrenal disease. 
•  The incidence of adrenal incidentalomas ranges between 0.5-4 % and the frequency of adrenal 
cancers among incidentalomas is extremely small with an estimated prevalence of 4–12 per million 
population.1-2
•  Adrenocortical carcinomas are extremely aggressive tumors and are mostly fatal if not identified early 
in the disease course. 
DISCUSSIONBACKGROUND
•  The diagnosis of adrenal carcinomas can easily be overlooked in incidentalomas of a young patient population, 
partly due to its rarity and partly due to the subclinical nature of the disease at early stages. 
•  There is lack of data on the true incidence of adrenal carcinoma in incidentalomas of young.  
•  There is high prevalence of benign adrenal cortical adenomas in incidentalomas with increasing age; hence the 
finding of an adrenal mass of any size in a young patient should increase the suspicion for malignant potential of 
the mass.2   
•  Features suggesting malignancy  include irregular or unclear margins, heterogeneity with mixed densities,  
attenuation (density) > 10 Hounsfield unit (HU) on unenhanced CT scan with rapidity of washout  of contrast 
medium < 50 % at 10 minutes and hyper intense lesion in relation to liver on T2 weighted imaging on MRI. 
•  Though most authors suspect malignancy in masses above 4 cm and recommend resection, the validity of that 
threshold is questionable in a much younger population. Adrenal cancer and metastatic cancers are the most 
difficult to diagnose especially at an early stage as they can often mimic adenomas in appearance at smaller 
sizes.6,7
•  As per AACE and AAES Guidelines, patients with adrenal incidentalomas smaller than 4 cm and radiologic 
characteristics consistent with a benign adenoma need to have radiographic reevaluation at 3 to 6 months and 
then annually for 1 to 2 years. Hormonal evaluation should be performed at the time of diagnosis and then annually 
for up to 5 years. AACE - American Association of Clinical Endocrinologists, AAES - American Association of 
Endocrine Surgeons.
•  These guidelines are largely based on a patient population with a median age of 60 years (range 34–79).10,11
•  5% of the patient population with adrenal incidentaloma can have subclinical cushing syndrome, which would 
require work up with 1-mg dexamethasone suppression test or urine free cortisol in addition to other routine 
hormonal work up. 
•  In a much younger population, a lower size threshold and a prompt initial diagnostic work up with a 
multidisciplinary approach involving an experienced radiologist, endocrinologist, a surgeon and a pathologist is 
warranted. 
CONCLUSION
•  Smaller an adrenocortical carcinoma at the time of diagnosis, the lower the tumor stage and the better the overall 
prognosis. 
•  Adrenal carcinomas are extremely aggressive and are invariably fatal if not diagnosed early. They have tendency to 
attain massive size as in our patient and causes significant debilitation.  
•  All adrenal incidentalomas especially in young age group require an immediate and an optimal diagnostic approach 
to rule out malignancy or secretory function, close biochemical and radiographic follow up. 
•  Adrenalectomy should be a consideration in the presence of autonomous hormonal secretion or if the mass 
enlarges by 1 cm or more during the period of observation.1
Table 1.
Lab Result Reference Values
Cortisol level 33 ug / dL 4.3 - 22.4 ug / dL
ACTH <10 pg / mL 10 - 60 pg / mL
24 hour urine cortisol 4796 ug / 24 hours 3.5 - 45 ug / 24 hr
Plasma metanephrine Normal
Plasma normetanephrine Normal
Serum aldosterone level Normal  
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Figure A: Right adrenal incidentaloma measuring 3cm x 2.6cm x 3cm.
Figure B: Heterogeneously enhancing mass in the right adrenal fossa 
increased in size to 8.9cmx9.1cmx6cm.
Figure C and D: Adrenal cortical carcinoma measuring 
27cmx15cmx 11cm occupying the entire hemi-abdomen abutting the 
liver, extending into retroperitoneum, compressing the inferior vena 
cava and encasing the renal vein.
